May we overcome the current serious limitations for distributing reconstituted mRNA vaccines?
Abstract
There is an urgent need to ameliorate the transport of the reconstituted vaccines to the vaccination sites to improve the COVID-19 vaccination campaigns. The maintenance of the integrity of the mRNA of the different COVID-19 reconstituted vaccines after continuous movement at room temperature during at least three hours ensures the safety of a ground transportation.
Related articles
Related articles are currently not available for this article.